Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: findings of the PERSPECTIVES study

Br J Ophthalmol. 2012 Oct;96(10):1351-4. doi: 10.1136/bjophthalmol-2011-301444. Epub 2012 Aug 7.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Aptamers, Nucleotide / therapeutic use*
  • Choroidal Neovascularization / complications*
  • Choroidal Neovascularization / diagnosis
  • Choroidal Neovascularization / drug therapy*
  • Early Diagnosis
  • Humans
  • Macular Degeneration / complications*
  • Middle Aged

Substances

  • Angiogenesis Inhibitors
  • Aptamers, Nucleotide
  • pegaptanib

Associated data

  • ClinicalTrials.gov/NCT00327470